Mills Lab Personnel:
Muneer G. Hasham, Associate Research Scientist
I.B. A.B. Ph.D.
Research Profile: I study the mechanism of XRCC2, an essential homologous recombination protein, in B-cell development and its impact on primary immunodeficiency and related disorders. My other scientific interests include studying secondary immunodeficiencies, infectious diseases and hematological cancers. I have been at The Jackson Laboratory since 2003, and a part of that in the Mills’ Laboratory.
Nina M. Donghia, Research Assistant II
Research Profile: Within my three years of experience in the Mills lab, I have learned many new concepts and techniques. In my work, I tend to gravitate throughout many of the existing projects within the Mills Laboratory. Currently, I am testing potential genomic sites of AID off-target, collateral damage, activity by co-FISH-immunostaining assays. Additionally, I am also testing potential leukemia/lymphoma chemotherapeutic agents that could more effectively eliminate only cancer cell machinery, leaving better prognosis for patients. In the future, I look forward to exploring new concepts and testing novel hypotheses when they arise.
Jane A. Branca, Biomedical Technologist I
Kristin R. Lamont, Ph.D., Postdoctoral Fellow
Research Profile: My project focuses upon the cytidine deaminase AID and its action in chronic lymphocytic leukemia. The action of AID is crucial in normal B-cell biology to generate antibody diversity and promote B-cell maturation, and evidence exists that AID might have a role in malignant progression as well. I completed my Ph.D. studies at the Mayo Clinic, where I studied the androgenic regulation of the anti-apoptotic protein, FLIP, in prostate cancers.
Kevin Mills, Ph.D.
Associate Professor
